Use of 3-O-sulfamoyloxy-7β-methyl-d-homo-6-oxaestra-1,3,5(10),8(9)-tetraen-17a-one to treat breast cancer
OwnerShamil Sionovich Ilyasov, Alexandr Grigorievich Shavva +1inventors
InventorsShamil Sionovich Ilyasov, Alexandr Grigorievich Shavva, Svetlana Nikolaevna Morozkina
Life of this patent
Estimating the term…
Abstract
The invention relates to the field of medicine and to the chemical and pharmacological industry, and concerns medicaments for the treatment of breast cancer. In particular the invention relates to a use of 3-O-sulfamoyloxy-7β-methyl-D-homo-6-oxaestra-1,3,5 (10),8(9)-tetraen-17a-one as an anti-cancer agent in monotherapy and adjuvant therapy of breast cancer, including the triple negative breast cancer.
Claims15
A compound, which is 3-O-sulfamoyloxy-7β-methyl-D-homo-6-oxaestra-1,3,5 (10),8 (9)-tetraen-17a-one of formula 2:
A method of treating cancer, the method comprising administering to a patient in need thereof an effective amount of 3-O-sulfamoyloxy-7β-methyl-D-homo-6-oxaestra-1,3,5 (10),8 (9)-tetraen-17a-one of formula 2:
A method of preparing 3-O-sulfamoyloxy-7β-methyl-D-homo-6-oxaestra-1,3,5 (10),8 (9)-tetraen-17a-one of formula (2), the method comprising the reactions as follows
Dependencies are inferred from the claim text.